Organometal-induced antinociception: a time- and dose-response comparison of triethyl and trimethyl lead and tin

Insights

Organolead and organotin compounds alter pain responses in rats. Different compounds show varied effects on hot plate latencies over time, with some causing delayed antinociception.

Area of Science:

  • Neurotoxicology
  • Behavioral Neuroscience
  • Environmental Health

Background:

  • Organolead and organotin compounds are known environmental contaminants.
  • Previous studies suggest these compounds can affect behavioral responses to pain.

Purpose of the Study:

  • To investigate the dose-response and temporal effects of various organolead and organotin compounds on pain reactivity.
  • To compare the neurobehavioral effects of triethyl lead (TEL), triethyl tin (TET), trimethyl lead (TML), and trimethyl tin (TMT).

Main Methods:

  • Male Fischer 344 rats were subcutaneously injected with varying doses (1/4, 1/2, 3/4 LD50) of TEL, TET, TML, TMT, or distilled water.
  • Animals were tested on a 57.5°C hot plate at 1, 7, 14, 21, and 28 days post-dosing to measure antinociceptive effects.
  • Behavioral observations for ataxia and akinesia were also recorded.

Main Results:

  • All four organometallic compounds altered hot plate latencies, with distinct dose and time-course effects.
  • Triethyl lead (TEL) showed a dose-related increase in latency, peaking at 1-7 days.
  • Trimethyl lead (TML) induced a delayed antinociception evident from day 14 onwards.
  • Trimethyl tin (TMT) and triethyl tin (TET) also demonstrated delayed effects on hot plate latencies, with TET also causing reversible ataxia and akinesia.

Conclusions:

  • Trialkyl lead and tin compounds exhibit differential neurobehavioral effects on pain sensitivity.
  • The observed effects are both time- and dose-dependent, highlighting the complexity of organometallic neurotoxicity.
  • These findings contribute to understanding the specific neurotoxic profiles of different organometallic compounds.

Related Concept Videos

Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...